Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ccf mtDNA as a Biomarker in Neurological and Neurodegenerative Diseases

NCT03938909 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT03938909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03938909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ccf mtDNA as a Biomarker in Neurological and Neurodegenerative Diseases
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
January 1, 2025
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurodegenerative diseases